Smart Watch Insights to Prevent Exacerbations and Recurrence - Health Study: SWIPER-HEALTH

Sponsor
Imperial College London (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT06011395
Collaborator
(none)
1,800
1
24
74.9

Study Details

Study Description

Brief Summary

Aims of the study:
  • To measure the rate of completion of a digital cardiac rehabilitation programme at Imperial College Healthcare NHS Trust (ICHNT)

  • To measure the health economic impact of a digital cardiac rehabilitation programme at ICHNT

Any adult patient eligible for ICHNT cardiac rehabilitation (CR) programmes is eligible to participate. Participants will receive a commercially available smart watch and be asked to wear the device as much as possible. In addition, they will be asked to download a smartphone application called 'Imperial Healthy Hearts', which displays movement and information on heart rate, breathing and oxygen levels to both the participant and the research team (digital data). The Healthy Hearts app also allows the direct care team to provide educational materials to patients as part of their routine care.

The clinical content and structure of the CR programme is determined by the clinical CR team, and does not deviate from established local and national standards and practices.

Researchers will capture physiological data such as heart rate, respiratory rate, blood pressure (where available) and oxygen saturation (where available) via the Healthy Hearts platform. Researchers will also capture clinical information from the electronic health record, and will compare CR programme uptake and completion rates with historical data and national targets.

Condition or Disease Intervention/Treatment Phase
  • Device: Smartwatch
  • Device: Imperial Healthy Hearts app

Study Design

Study Type:
Observational
Anticipated Enrollment :
1800 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Smart Watch Insights to Prevent Exacerbations and Recurrence - Health Study: SWIPER-HEALTH
Anticipated Study Start Date :
Aug 30, 2023
Anticipated Primary Completion Date :
Aug 30, 2025
Anticipated Study Completion Date :
Aug 30, 2025

Outcome Measures

Primary Outcome Measures

  1. Uptake of cardiac rehabilitation [12 months]

    Percentage uptake of cardiac rehabilitation programme (of those that are eligible)

Secondary Outcome Measures

  1. Quality of life assessment (EQ-5D-5L) [12 months]

    Patient quality of life as measured by the EQ-5D-5L instrument

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Age 18 years or above

  • Able to give informed consent

  • Eligible for Cardiac Rehabilitation programme

Exclusion Criteria:
  • Any wrist wound, skin pathology or other feature that would prohibit the wearing of a smartwatch

  • Any visual impairment preventing the use of the Fitbit or smartphone application.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Imperial College Healthcare NHS Trust London United Kingdom

Sponsors and Collaborators

  • Imperial College London

Investigators

  • Principal Investigator: Nicholas S Peters, MD, Imperial College London

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Imperial College London
ClinicalTrials.gov Identifier:
NCT06011395
Other Study ID Numbers:
  • 22HH7635
First Posted:
Aug 25, 2023
Last Update Posted:
Aug 25, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Imperial College London
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 25, 2023